Skip to main content
Log in

Intraventricular Fibrinolysis for Intracerebral Hemorrhage with Severe Ventricular Involvement

  • Review Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Intraventricular hemorrhage (IVH) has been associated with poor prognosis in patients with spontaneous intracerebral hemorrhage. Several factors contribute to the deleterious effects of IVH, including direct mass effects of the ventricular blood clot on ependymal and subependymal brain structures, mechanical and inflammatory impairment of the Pacchioni granulations by blood and its breakdown products, and disturbance of physiological cerebrospinal fluid (CSF) circulation. Acute obstructive hydrocephalus represents a major life-threatening complication of IVH and is usually treated with an external ventricular drainage (EVD). However, treatment with EVD alone is frequently not sufficiently effective due to obstruction of the catheter by blood. In the past two decades, intraventricular fibrinolysis (IVF) has been increasingly used for maintenance of EVD functionality and acceleration of ventricular clot resolution in such patients. Unfortunately, there is no prospective, randomized controlled trial addressing the effect of IVF on clinical outcome. The available data on IVF consist of small retrospective case series, case reports, and a few prospective case–control studies, which are the subject of the present review article. All these studies, when considered in their entirety, suggest that IVF has a positive impact on mortality and functional outcome, and could be considered as a treatment option for selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999;27:617–21.

    Article  PubMed  CAS  Google Scholar 

  2. Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl. 2006;96:65–8.

    Article  PubMed  CAS  Google Scholar 

  3. Steiner T, Diringer MN, Schneider D, et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery. 2006;59:767–73. (discussion 73–4).

    Article  PubMed  Google Scholar 

  4. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632–44.

    Article  PubMed  Google Scholar 

  5. Sjoblom L, Hardemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke. 2001;32:2567–74.

    Article  PubMed  CAS  Google Scholar 

  6. Huttner HB, Kohrmann M, Berger C, Georgiadis D, Schwab S. Predictive factors for tracheostomy in neurocritical care patients with spontaneous supratentorial hemorrhage. Cerebrovasc Dis. 2006;21:159–65.

    Article  PubMed  Google Scholar 

  7. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.

    Article  PubMed  CAS  Google Scholar 

  8. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke. 1998;29:1352–7.

    Article  PubMed  CAS  Google Scholar 

  9. Shapiro SA, Campbell RL, Scully T. Hemorrhagic dilation of the fourth ventricle: an ominous predictor. J Neurosurg. 1994;80:805–9.

    Article  PubMed  CAS  Google Scholar 

  10. Ozdemir O, Calisaneller T, Hasturk A, Aydemir F, Caner H, Altinors N. Prognostic significance of third ventricle dilation in spontaneous intracerebral hemorrhage: a preliminary clinical study. Neurol Res. 2008; 30(4):406–10.

    Google Scholar 

  11. Findlay JM, Jacka MJ. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery. 2004;55:532–7. (discussion 7–8).

    Article  PubMed  Google Scholar 

  12. Torres A, Plans G, Martino J, et al. Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment. Br J Neurosurg. 2008;22:269–74.

    Article  PubMed  CAS  Google Scholar 

  13. Adams RE, Diringer MN. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology. 1998;50:519–23.

    PubMed  CAS  Google Scholar 

  14. Mayfrank L, Kissler J, Raoofi R, et al. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke. 1997;28:141–8.

    Article  PubMed  CAS  Google Scholar 

  15. Engelhard HH, Andrews CO, Slavin KV, Charbel FT. Current management of intraventricular hemorrhage. Surg Neurol. 2003;60:15–21. (discussion 2).

    Article  PubMed  Google Scholar 

  16. Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose–effect relationship. J Neurol Sci. 2002;202:35–41.

    Article  PubMed  CAS  Google Scholar 

  17. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model. Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery. 1986;19:553–72.

    Article  PubMed  CAS  Google Scholar 

  18. Huttner HB, Nagel S, Tognoni E, et al. Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydrocephalus. Stroke. 2007;38:183–7.

    Article  PubMed  Google Scholar 

  19. Tung MY, Ong PL, Seow WT, Tan KK. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg. 1998;12:234–9.

    Article  PubMed  CAS  Google Scholar 

  20. Akdemir H, Selcuklu A, Pasaoglu A, Oktem IS, Kavuncu I. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev. 1995;18:95–100.

    Article  PubMed  CAS  Google Scholar 

  21. Coplin WM, Vinas FC, Agris JM, et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke. 1998;29:1573–9.

    Article  PubMed  CAS  Google Scholar 

  22. Gubucz I, Kakuk I, Major O, et al. Effectiveness and safety of intraventricular fibrinolysis in secondary intraventricular hemorrhages (a prospective, randomized study). Orv Hetil. 2004;145:1609–15.

    PubMed  Google Scholar 

  23. Lee MW, Pang KY, Ho WW, Wong CK. Outcome analysis of intraventricular thrombolytic therapy for intraventricular haemorrhage. Hong Kong Med J. 2003;9:335–40.

    PubMed  CAS  Google Scholar 

  24. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke. 2000;31:841–7.

    Article  PubMed  CAS  Google Scholar 

  25. Naff NJ, Hanley DF, Keyl PM, et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery. 2004;54:577–83. (discussion 83–4).

    Article  PubMed  Google Scholar 

  26. Rainov NG, Burkert WL. Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir (Wien). 1995;134:55–9.

    Article  CAS  Google Scholar 

  27. Rajendra T, Kumar K, Liang LH. Hypertensive primary intraventricular hemorrhage due to a phaeochromocytoma. ANZ J Surg. 2006;76:664–7.

    Article  PubMed  Google Scholar 

  28. Shen PH, Matsuoka Y, Kawajiri K, et al. Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo). 1990;30:329–33.

    Article  CAS  Google Scholar 

  29. Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg. 1991;74:81–6.

    Article  PubMed  CAS  Google Scholar 

  30. Tush GM, Tesoro EP, Prabhu S, Brown K, Bullock MR. Intraventricular urokinase for the treatment of intraventricular hemorrhage (abstract). Crit Care Med. 1999;27:A79.

    Article  Google Scholar 

  31. Azmi-Ghadimi H, Heary RF, Farkas JE, Hunt CD. Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports. Neurosurgery. 2002;50:421–4. (discussion 4–5).

    PubMed  Google Scholar 

  32. Deutsch H, Rodriguez JC, Titton RL. Lower dose intraventricular T-PA fibrinolysis: case report. Surg Neurol. 2004;61:460–3. (discussion 3).

    Article  PubMed  Google Scholar 

  33. Findlay JM, Grace MG, Weir BK. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery. 1993;32:941–7. (discussion 7).

    Article  PubMed  CAS  Google Scholar 

  34. Findlay JM, Weir BK, Stollery DE. Lysis of intraventricular hematoma with tissue plasminogen activator. Case report. J Neurosurg. 1991;74:803–7.

    Article  PubMed  CAS  Google Scholar 

  35. Fountas KN, Kapsalaki EZ, Parish DC, et al. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage. South Med J. 2005;98:767–73.

    Article  PubMed  CAS  Google Scholar 

  36. Goh KY, Poon WS. Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage. Surg Neurol. 1998;50:526–31. (discussion 31–2).

    Article  PubMed  CAS  Google Scholar 

  37. Grabb PA. Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: technical case report. Neurosurgery. 1998;43:966–9.

    Article  PubMed  CAS  Google Scholar 

  38. Hall B, Parker D Jr, Carhuapoma JR. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling. Neurocrit Care. 2005;3:153–6.

    Article  PubMed  Google Scholar 

  39. Ionita CC, Ferrara J, McDonagh DL, Grossi P, Graffagnino C. Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage. Neurocrit Care. 2005;3:246–8.

    Article  PubMed  Google Scholar 

  40. Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien). 1993;122:32–8.

    Article  CAS  Google Scholar 

  41. Mayfrank L, Rohde V, Gilsbach JM. Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations. Br J Neurosurg. 1999;13:128–31.

    Article  PubMed  CAS  Google Scholar 

  42. Prat-Acin R, Galeano-Senabre I, Conde-Garcia FJ, Febles-Garcia P, Gonzalez-Feria L. Fibrinolytic treatment of cerebral intraventricular hemorrhage. Rev Neurol. 2001;33:544–7.

    PubMed  CAS  Google Scholar 

  43. Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry. 1995;58:447–51.

    Article  PubMed  CAS  Google Scholar 

  44. Schwarz S, Schwab S, Steiner HH, Hanley D, Hacke W. Fibrinolysis of intraventricular hematoma with rt-PA. Nervenarzt. 1999;70:123–30.

    Article  PubMed  CAS  Google Scholar 

  45. Slavin KV, Ausman JI, Charbel FT, Andrews C, Misra M, Munoz LF. Results of the treatment of intraventricular hemorrhage with recombinant tissue plasminogen activator in a series of 10 patients (abstract). J Neurosurg. 1998;88:194a.

    Google Scholar 

  46. Varelas PN, Rickert KL, Cusick J, et al. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery. 2005;56:205–13. (discussion 13).

    Article  PubMed  Google Scholar 

  47. Vereecken KK, Van Havenbergh T, De Beuckelaar W, Parizel PM, Jorens PG. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator: a clinical study of 18 cases. Clin Neurol Neurosurg. 2006;108:451–5.

    Article  PubMed  Google Scholar 

  48. Huttner HB, Schwab S, Bardutzky J. Lumbar drainage for communicating hydrocephalus after ICH with ventricular hemorrhage. Neurocrit Care. 2006;5:193–6.

    Article  PubMed  Google Scholar 

  49. Huttner HB, Tognoni E, Bardutzky J, et al. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case–control study. Eur J Neurol. 2008;15:342–9.

    Article  PubMed  CAS  Google Scholar 

  50. Goh KY, Hsiang JN, Zhu XL, Poon WS. Intraventricular recombinant tissue plasminogen activator for treatment of spontaneous intraventricular haemorrhage in pregnancy. J Clin Neurosci. 1999;6:158–9.

    Article  PubMed  CAS  Google Scholar 

  51. Jorens PG, Menovsky TM, Voormolen MH, Van Den Brande E, Parizel PM. Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations. No absolute contraindications as rescue therapy prior to surgical repair or embolisation? Clin Neurol Neurosurg 2009;111(6):544–50.

    Article  PubMed  Google Scholar 

  52. Staykov D, Huttner HB, Lunkenheimer J, et al. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage. J Neurol Neurosurg Psychiatry. 2010;81:105–8.

    Article  PubMed  CAS  Google Scholar 

  53. Staykov D, Huttner HB, Struffert T, et al. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke. 2009;40:3275–80.

    Article  PubMed  Google Scholar 

  54. Hayashi M, Handa Y, Kobayashi H, Kawano H, Nozaki J. Management of intraventricular haemorrhage in patients with haemorrhagic cerebrovascular diseases. Br J Neurosurg. 1988;2:23–32.

    Article  PubMed  CAS  Google Scholar 

  55. Hanley D. Final results CLEARIVH Trial: clot lysis, safety and 30 day functional outcomes. In: European stroke conference, Nice, France, 13–16th May 2008.

  56. Morgan T, Awad I, Keyl P, Lane K, Hanley D. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008;105:217–20.

    Article  PubMed  CAS  Google Scholar 

  57. Huttner HB, Kohrmann M, Berger C, Georgiadis D, Schwab S. Influence of intraventricular hemorrhage and occlusive hydrocephalus on the long-term outcome of treated patients with basal ganglia hemorrhage: a case–control study. J Neurosurg. 2006;105:412–7.

    Article  PubMed  Google Scholar 

  58. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51:170–81. (discussion 81–2).

    Article  PubMed  Google Scholar 

  59. Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 2000;247:117–21.

    Article  PubMed  CAS  Google Scholar 

  60. Hayashi M, Handa Y, Kobayashi H, Kawano H, Nozaki J, Hirose S. Prognosis of intraventricular hemorrhage due to hypertensive hemorrhagic cerebrovascular disease. Zentralbl Neurochir. 1988;49:101–8.

    PubMed  CAS  Google Scholar 

  61. Mayr U, Bauer P, Fischer J. Non-traumatic intracerebral haemorrhage. Prognostic implications of neurological and computer-tomographical findings in 100 consecutive patients. Neurochirurgia. 1983;26:36–41.

    PubMed  CAS  Google Scholar 

  62. Pia HW. Spontaneous intracerebral hematomas. Advances in diagnosis and therapy. Berlin, Heidelberg, New York: Springer; 1980.

    Google Scholar 

  63. Matsumoto K, Hondo H. CT-guided stereotaxic evacuation of hypertensive intracerebral hematomas. J Neurosurg. 1984;61:440–8.

    Article  PubMed  CAS  Google Scholar 

  64. Ikeda Y, Nakazawa S, Higuchi H, Ueda K, Yajima K. Clinical aspects and prognosis of intraventricular hemorrhage with cerebrovascular disease. CT findings and etiological analysis. Neurol Med Chir (Tokyo). 1982;22:822–8.

    Article  CAS  Google Scholar 

  65. Lu B. Hypertensive putaminal hemorrhage with intraventricular hemorrhage–50 clinical cases and 6 pathoanatomy cases. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1989;22:328–30, 381.

    Google Scholar 

  66. Ruscalleda J, Peiro A. Prognostic factors in intraparenchymatous hematoma with ventricular hemorrhage. Neuroradiology. 1986;28:34–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitre Staykov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staykov, D., Bardutzky, J., Huttner, H.B. et al. Intraventricular Fibrinolysis for Intracerebral Hemorrhage with Severe Ventricular Involvement. Neurocrit Care 15, 194–209 (2011). https://doi.org/10.1007/s12028-010-9390-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-010-9390-x

Keywords

Navigation